Sartorius Stedim Biotech annual debt-to-assets ratio
2020
2021
2022
2023
2024
2025
Sartorius Stedim Biotech Debt-to-Assets Ratio Growth & History (DIM)
Sartorius Stedim Biotech's debt-to-assets ratio was 0.33 for fiscal 2025.
View full Sartorius Stedim Biotech company overviewSartorius Stedim Biotech annual debt-to-assets ratio history
| Fiscal year | Period ended | Debt-to-assets ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.33 | −0.02 | −6.33% |
| 2024 | 2024-12-31 | 0.35 | −0.13 | −27.03% |
| 2023 | 2023-12-31 | 0.48 | 0.25 | +112.44% |
| 2022 | 2022-12-31 | 0.22 | 0.07 | +41.63% |
| 2021 | 2021-12-31 | 0.16 | −0.05 | −22.97% |
| 2020 | 2020-12-31 | 0.21 | — | — |
Sartorius Stedim Biotech quarterly debt-to-assets ratio
Q1.25
Q2.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Debt-to-assets ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.30 | −0.05 | −15.05% |
| Q1 2026 | 2026-03-31 | 0.32 | −0.03 | −9.61% |
| Q4 2025 | 2025-12-31 | 0.33 | — | — |
| Q2 2025 | 2025-06-30 | 0.36 | — | — |
| Q1 2025 | 2025-03-31 | 0.35 | — | — |
Sartorius Stedim Biotech debt-to-assets ratio trends
Over the last five fiscal years, Sartorius Stedim Biotech's debt-to-assets ratio increased from 0.21 to 0.33, a change of 0.12. The latest reported quarter, Q2 2026, shows 0.30.
About the metric
What the debt-to-assets ratio means
The debt-to-assets ratio shows the portion of a company’s reported assets financed with interest-bearing debt. It is a leverage measure and should not be confused with total liabilities divided by assets.
Calculation and source
How debt-to-assets is calculated
TickerStat calculates debt-to-assets as total interest-bearing debt divided by total assets at the same reporting-period end. Periods with missing debt or non-positive assets are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Sartorius Stedim Biotech source filings ↗